查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1732840

臨床前影像市場－全球產業規模、佔有率、趨勢、機會和預測（按模式、按應用、按最終用戶、按地區和按競爭分類，2020 年至 2030 年）

Preclinical Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球臨床前影像市場價值為 51.3 億美元，預計到 2030 年將達到 72.7 億美元，預測期內複合年成長率為 5.94%。臨床前影像是生物醫學研究的重要組成部分，它提供非侵入性技術來視覺化和監測動物模型中的生物過程。這使科學家能夠研究疾病進展、評估藥物療效並制定個人化醫療策略。由於藥物研發投資的增加、早期疾病研究需求的增加以及慢性病盛行率的不斷上升，市場正在迅速擴張。 MRI、PET、CT 和光學成像等方式在這些應用中發揮核心作用。成像技術的融合以及成像解析度和資料分析的進步正在進一步增強研究能力。全球對臨床前影像在加速醫學創新方面價值的認知不斷提高，預計將在預測期內維持強勁的市場勢頭。

市場概覽
預測期 2026-2030
2024年市場規模 51.3億美元
2030年市場規模 72.7億美元
2025-2030 年複合年成長率 5.94%
成長最快的領域 藥物研發
最大的市場 北美洲

關鍵市場促進因素

想像一下，無需侵入性手術就能見證疾病進展、藥物療效以及生物過程的複雜細節。

主要市場挑戰

技術和基礎設施成本

主要市場趨勢

多模態成像整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球臨床前影像市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按模式（光學影像系統、核子造影系統、微型 MRI、微型超音波、微型 CT、光聲成像系統、其他）
    • 按應用（研發、藥物發現）
    • 按最終用戶（生物技術及製藥公司、學術及研究機構、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美臨床前影像市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 按應用
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臨床前影像市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太臨床前影像市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美臨床前影像市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷

第 10 章：中東和非洲臨床前影像市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球臨床前影像市場：SWOT 分析

第 14 章：競爭格局

  • Aspect Imaging Ltd
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Mediso Ltd
  • MR Solutions Ltd
  • PerkinElmer Inc.
  • United Imaging Healthcare Co. Ltd
  • AXT PTY LTD
  • Advanced Molecular Vision, Inc.

第 14 章：10 IVIM Technology Corp.Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16126

The Global Preclinical Imaging Market was valued at USD 5.13 billion in 2024 and is projected to reach USD 7.27 billion by 2030, growing at a CAGR of 5.94% during the forecast period. Preclinical imaging is a critical component of biomedical research, offering non-invasive techniques to visualize and monitor biological processes in animal models. This enables scientists to study disease progression, evaluate drug efficacy, and develop personalized medicine strategies. The market is expanding rapidly due to rising investment in drug discovery, increasing demand for early-stage disease research, and the growing prevalence of chronic conditions. Modalities such as MRI, PET, CT, and optical imaging play a central role in these applications. The integration of imaging technologies and advancements in imaging resolution and data analysis are further enhancing research capabilities. Increased global awareness of the value of preclinical imaging in accelerating medical innovation is expected to sustain strong market momentum over the forecast period.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.13 Billion
Market Size 2030USD 7.27 Billion
CAGR 2025-20305.94%
Fastest Growing SegmentDrug Discovery
Largest MarketNorth America

Key Market Drivers

Imagine having the ability to witness disease progression, drug efficacy, and the intricate details of biological processes without invasive procedures.

This is the transformative promise of preclinical imaging. Techniques such as MRI, PET, and CT scans offer unparalleled insights into disease mechanisms, treatment effects, and biological responses in real time. These technologies have become indispensable tools across medical research fields, including oncology, cardiology, and neurology. Their utility in visualizing tissue response and pharmacokinetics contributes to faster and more effective drug development. As the demand for targeted therapies and personalized medicine grows, so does the reliance on sophisticated imaging systems that can provide early and accurate biological assessments, propelling the growth of the preclinical imaging market globally.

Key Market Challenges

Cost of Technology and Infrastructure

The high cost of acquiring, maintaining, and operating advanced imaging equipment remains a significant barrier in the preclinical imaging space. Technologies like MRI, PET, and CT scanners involve substantial capital investment, which can be prohibitive for small and mid-sized research facilities. Additionally, ongoing maintenance, software upgrades, and the need for highly skilled personnel add to the financial burden. According to a 2024 NIH report, over 45% of life science laboratories identified training and equipment maintenance as major financial challenges. These cost-related issues can limit access to cutting-edge imaging tools, thereby constraining innovation and adoption in emerging and resource-limited markets.

Key Market Trends

Multi-Modal Imaging Integration

A key trend in the Global Preclinical Imaging Market is the growing adoption of multi-modal imaging systems. By integrating technologies like MRI, PET, CT, and optical imaging, researchers can simultaneously obtain anatomical, functional, and molecular data. Each modality offers unique strengths: for example, MRI provides high-resolution anatomical detail, while PET allows for the visualization of metabolic processes. The combination of these approaches enables a more comprehensive analysis, improving the depth and accuracy of preclinical studies. As integration technology becomes more cost-effective and accessible, multi-modal imaging is expected to become a standard in research environments seeking to maximize data quality and operational efficiency.

Key Market Players

  • Aspect Imaging Ltd
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Mediso Ltd
  • MR Solutions Ltd
  • PerkinElmer Inc.
  • United Imaging Healthcare Co. Ltd
  • AXT PTY LTD
  • Advanced Molecular Vision, Inc.
  • IVIM Technology Corp

Report Scope

In this report, the Global Preclinical Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Preclinical Imaging Market, By Modality:

  • Optical Imaging Systems
  • Nuclear Imaging Systems
  • Micro-MRI
  • Micro-ultrasound
  • Micro-CT
  • Photoacoustic Imaging Systems
  • Other

Preclinical Imaging Market, By Application:

  • Research and Development
  • Drug Discovery

Preclinical Imaging Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others

Preclinical Imaging Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Preclinical Imaging Market.

Available Customizations

Global Preclinical Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Preclinical Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-ultrasound, Micro-CT, Photoacoustic Imaging Systems, Other)
    • 5.2.2. By Application (Research and Development, Drug Discovery)
    • 5.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Preclinical Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Modality
  • 6.2.2 By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Preclinical Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Modality
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Preclinical Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Modality
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Preclinical Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Modality
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Preclinical Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Modality
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Preclinical Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Modality
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Preclinical Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Modality
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Preclinical Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Modality
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Preclinical Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Modality
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Preclinical Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Modality
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Preclinical Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Modality
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Preclinical Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Modality
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Preclinical Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Modality
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Preclinical Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Modality
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Preclinical Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Modality
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Preclinical Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Modality
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Preclinical Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Modality
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Preclinical Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Modality
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Preclinical Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Modality
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Preclinical Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Modality
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Preclinical Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Modality
    • 10.2.1 By Application
    • 10.2.2.By End User
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Preclinical Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Modality
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Preclinical Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Modality
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Preclinical Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Modality
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Preclinical Imaging Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Aspect Imaging Ltd
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Bruker Corporation
  • 14.3. Fujifilm Holdings Corporation
  • 14.4. Mediso Ltd
  • 14.5. MR Solutions Ltd
  • 14.6. PerkinElmer Inc.
  • 14.7. United Imaging Healthcare Co. Ltd
  • 14.8. AXT PTY LTD
  • 14.9. Advanced Molecular Vision, Inc.
  • 14.10 IVIM Technology Corp.Inc.

15. Strategic Recommendations

16. About Us & Disclaimer